On Wednesday, President Biden at the White House officially endorsed the vaccine booster stating, “It’s the best way to protect ourselves from new variants. The COVID-19 vaccine, very much like the flu vaccine, will require a booster shot. Unlike the flu shot, however, that is received annually, the COVID-19 booster shot will be administered eight months after the second shot.
And there is evidence proving why the booster vaccine is essential. ON WEDNESDAY, the CDC director Dr. Rochelle Walensky said, “The data consistently demonstrates a reduction in effectiveness against infection over time.” This was further supported by Dr. Anthony Fauci, Biden’s chief medical advisor. Dr. Fauci provided evidence that showed that the third shot of either mRNA increased antibodies in the body against the COVID-19 virus.
In the U.S., health officials are preparing to roll out these COVID-19 booster shots. The announcement made on Wednesday has raised numerous questions like who is eligible to get the booster shot? Any adult that is fully vaccinated received the first and second COVID-19 vaccine is eligible. However, this is only for those who received the Pfizer and Moderna vaccine. It is still unclear what the next cause of action is for those that received the Johnson and Johnson COVID vaccine. The booster vaccine is currently available for those who received an mRNA. The president made it clear that the vaccine booster was free.
With the announcement of the vaccine being made very soon, many people might be wondering whether it spells doom. You needn’t worry if you were fully vaccinated; you are still very protected against the virus. The booster shot is a measure set in motion to prevent any COVID-19 related deaths in the future as the effectiveness of the two-does vaccine declines.
The booster shots are expected to be available starting the week of September 20. The CDC does not recommend any booster shots for immunocompromised individuals. That being because such individuals have a higher risk of developing a prolonged illness.
The groundbreaking announcement is not without criticism; some critics feel that with some countries still struggling to offer the first two doses, the U.S. should focus on offering assistance to these nations.